JP2023525527A5 - - Google Patents
Info
- Publication number
- JP2023525527A5 JP2023525527A5 JP2022568549A JP2022568549A JP2023525527A5 JP 2023525527 A5 JP2023525527 A5 JP 2023525527A5 JP 2022568549 A JP2022568549 A JP 2022568549A JP 2022568549 A JP2022568549 A JP 2022568549A JP 2023525527 A5 JP2023525527 A5 JP 2023525527A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- symptoms
- independently
- diseases
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022627P | 2020-05-11 | 2020-05-11 | |
| US63/022,627 | 2020-05-11 | ||
| PCT/US2021/031479 WO2021231243A1 (en) | 2020-05-11 | 2021-05-10 | Small molecule inhibitors of galectin-3 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023525527A JP2023525527A (ja) | 2023-06-16 |
| JP2023525527A5 true JP2023525527A5 (cg-RX-API-DMAC10.html) | 2024-05-20 |
| JP7677995B2 JP7677995B2 (ja) | 2025-05-15 |
Family
ID=76284161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568549A Active JP7677995B2 (ja) | 2020-05-11 | 2021-05-10 | ガレクチン-3の低分子阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12286424B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4149939A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7677995B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230009433A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115551850A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021231243A1 (cg-RX-API-DMAC10.html) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| KR102231732B1 (ko) | 2012-10-10 | 2021-03-23 | 갈렉틴 테라퓨틱스, 인크. | 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물 |
| IN2015DN02573A (cg-RX-API-DMAC10.html) | 2012-10-31 | 2015-09-11 | Galecto Biotech Ab | |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| CA3000924A1 (en) | 2015-11-09 | 2017-05-18 | Galecto Biotech Ab | Novel galactoside inhibitors of galectins |
| KR102626669B1 (ko) * | 2017-05-12 | 2024-01-17 | 갈랙틴 사이언시즈, 엘엘씨 | 질환의 예방 및 치료를 위한 화합물 및 이의 용도 |
| CA3062649A1 (en) * | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| US12269819B2 (en) * | 2019-04-10 | 2025-04-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
-
2021
- 2021-05-10 WO PCT/US2021/031479 patent/WO2021231243A1/en not_active Ceased
- 2021-05-10 US US17/998,261 patent/US12286424B2/en active Active
- 2021-05-10 CN CN202180034243.5A patent/CN115551850A/zh active Pending
- 2021-05-10 KR KR1020227042914A patent/KR20230009433A/ko active Pending
- 2021-05-10 JP JP2022568549A patent/JP7677995B2/ja active Active
- 2021-05-10 EP EP21730348.6A patent/EP4149939A1/en active Pending